These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 26195208)

  • 1. Treatment of Overt Hepatic Encephalopathy.
    Sussman NL
    Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
    Alsahhar JS; Rahimi RS
    Curr Opin Gastroenterol; 2019 May; 35(3):145-154. PubMed ID: 30893082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Ammonia-Lowering Agents for Hepatic Encephalopathy.
    Rahimi RS; Rockey DC
    Clin Liver Dis; 2015 Aug; 19(3):539-49. PubMed ID: 26195207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Therapies in Hepatic Encephalopathy.
    Alimirah M; Sadiq O; Gordon SC
    Clin Liver Dis; 2020 May; 24(2):303-315. PubMed ID: 32245535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the Therapeutic Management of Hepatic Encephalopathy.
    Kornerup LS; Gluud LL; Vilstrup H; Dam G
    Curr Gastroenterol Rep; 2018 Apr; 20(5):21. PubMed ID: 29644492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and treatment of hepatic encephalopathy].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic encephalopathy.
    Khungar V; Poordad F
    Clin Liver Dis; 2012 May; 16(2):301-20. PubMed ID: 22541700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal treatment of hepatic encephalopathy.
    Waghray A; Waghray N; Kanna S; Mullen K
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic Management of Hepatic Encephalopathy.
    Mahpour NY; Pioppo-Phelan L; Reja M; Tawadros A; Rustgi VK
    Clin Liver Dis; 2020 May; 24(2):231-242. PubMed ID: 32245530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis.
    Irimia R; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1021-7. PubMed ID: 23700882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of overt hepatic encephalopathy.
    Khungar V; Poordad F
    Clin Liver Dis; 2012 Feb; 16(1):73-89. PubMed ID: 22321466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hepatic encephalopathy in the hospital.
    Leise MD; Poterucha JJ; Kamath PS; Kim WR
    Mayo Clin Proc; 2014 Feb; 89(2):241-53. PubMed ID: 24411831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic encephalopathy due to liver cirrhosis.
    Ellul MA; Gholkar SA; Cross TJ
    BMJ; 2015 Aug; 351():h4187. PubMed ID: 26265724
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.
    Sharma BC; Sharma P; Lunia MK; Srivastava S; Goyal R; Sarin SK
    Am J Gastroenterol; 2013 Sep; 108(9):1458-63. PubMed ID: 23877348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
    Ahire K; Sonawale A
    J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontraditional Treatment of Hepatic Encephalopathy.
    Singh J; Ibrahim B; Han SH
    Clin Liver Dis; 2024 May; 28(2):297-315. PubMed ID: 38548441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic encephalopathy: a critical current review.
    Hadjihambi A; Arias N; Sheikh M; Jalan R
    Hepatol Int; 2018 Feb; 12(Suppl 1):135-147. PubMed ID: 28770516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What?
    Henderson PK; Herrera JL
    Clin Liver Dis; 2015 Aug; 19(3):487-95. PubMed ID: 26195203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.